CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x September 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China)] [Hainan Helpson Medical & Biotechnology Long-term Laborntract Employer:Hainan Helpson Medical & Biotechnology (hereunderlled Party A ormpany) Zhilin Li Legal Representative/ authorisedent: Unit 8, D Area, Office Hall, Haikou Bonded Zone, Haikou Party A'sdress: 570216 Postde: Zhilin Li (hereunderlled Party B)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:November 10, 2010 -------------------------------- President and Chief Executive Officer cphi10qex321093010.htm 5 EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:November 10, 2010 --------------------- (principal financial officer and principal accounting officer) cphi10qex322093010.htm 6 EX-32.2]

By | 2016-02-07T23:23:17+00:00 November 10th, 2010|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

HPJ [Highpower International] 8-K: Highpower International, Inc. Reports Third Quarter 2010 Financial

[Highpower International, Inc. Reports Third Quarter 2010 Financial Results New York , USA & Shenzhen , China – November 10 , 2010 – Highpower International , Inc. ( NasdaqGM : HPJ) Business Highlights · Achieved 32% increase in net sales to $27.8 million for third quarter 2010 from $21.1 million in third quarter 2009; · Gross profit grew 13% year-over-year] [(86) 755-89686238 ¨ ¨ ¨ ¨ Item 2.02 Results of Operations and Financial Condition. On November 10, 2010, Highpower International, Inc. (the “Company”) issued a press release announcing its financial results for the three and nine months ended September 30, 2010.]

BIDU [Baidu] SC 13G/A: (Original Filing)

[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 125,121 Item 6: 0 Item 7: 1,130,382 Item 8: 0 Item 9: 1,130,382 Item 11: 4.252% Item 12: HC Cusip #G07034104 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 1,130,382 Item 8: 0 Item 9: 1,130,382 Item 11: 4.252%]

CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x September 30, 2010

[FORM 10-Q (Mark One) x September 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China)] [Hainan Helpson Medical & Biotechnology Long-term Laborntract Employer:Hainan Helpson Medical & Biotechnology (hereunderlled Party A ormpany) Zhilin Li Legal Representative/ authorisedent: Unit 8, D Area, Office Hall, Haikou Bonded Zone, Haikou Party A'sdress: 570216 Postde: Zhilin Li (hereunderlled Party B)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:November 10, 2010 -------------------------------- President and Chief Executive Officer cphi10qex321093010.htm 5 EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:November 10, 2010 --------------------- (principal financial officer and principal accounting officer) cphi10qex322093010.htm 6 EX-32.2]

By | 2016-02-07T23:23:50+00:00 November 10th, 2010|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] SC 13G: (Original Filing)

[(Name of Issuer) Common Stock (Title of Class of Securities) P8696W104 (CUSIP Number) October 31, 2010 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. P8696W104 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 3. SEC USE ONLY]

By | 2016-03-24T02:37:34+00:00 November 10th, 2010|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] SC 13G: (Name of Issuer) Common Stock (Title of Class

[(Name of Issuer) Common Stock (Title of Class of Securities) P8696W104 (CUSIP Number) October 31, 2010 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. P8696W104 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 3. SEC USE ONLY]

By | 2016-03-24T02:38:55+00:00 November 10th, 2010|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar